Veterinary Healthcare Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Veterinary Healthcare Market By Product Type (Drugs (Antibiotics, Antifungal, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Drugs for Chronic Diseases, and Others), Vaccines, and Feed Additives (Nutritional Feed Additives and Medicinal Feed Additives)), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global veterinary healthcare market size estimated to be valued US$ 37.4 Bn in 2020 at CAGR of 4.9% and expected to reach US$ 49.3 Bn by 2026 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe. The rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period. Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large-scale production of animals in the form of factory farming expected to boost the animal healthcare market. Animals have long been considered as a source of food for the human being and it’s been shifting towards companionship to the humans. As there is a growing interaction between humans and animals prompting the key stakeholders to give attention to animal healthcare. The rising incidences of zoonotic disease in several developed and developing countries expected to create demand for animal healthcare products like drugs and vaccines over the forecast period. According to U.S. Centre for disease control and Prevention (CDC) every year tens of thousands of people get sick due to disease spread from animals to humans and it is believed that more than six out of every 10 known infectious diseases in people are spread from animals, and three out of every four new or emerging infectious diseases in people are spread from animals, which can be prevented by appropriate health care to animals. In addition, This report includes animal demographics; regulatory scenario, top meat-producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary healthcare market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Veterinary Healthcare Market

MARKET SUMMARY
-
4.9% CAGR
  • Study Period– 2021 – 2026
  • Base Year– 2020
  • CAGR– 4.9%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Veterinary Healthcare Market

  • The report on global veterinary healthcare market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel and geographic regions.
  • veterinary healthcare market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • This report studies  market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary healthcare products.
Market Key Players
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Cargill, Inc. (U.S)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
Drivers And Restraints

Veterinary Healthcare Market

A huge growth in global demand for protein food, as well as an increase in the frequency of zoonotic and food-borne diseases, are driving the industry. Companies have been spurred to develop enhanced vaccines and medications as a result of the enormous growth in disease prevalence. As a result of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion.


North-America got significant share

Veterinary Healthcare Market

North America accounted for larger revenue share in global animal healthcare market with moderate CAGR. There has been increasing awareness among cattlemen in U.S. regarding animal rearing, animal health and proper vaccination and judicious use of antibiotics in animals, which are driving the market revenue growth in the region. Asia Pacific market projected to grow at significant rate owing large pool of animal population coupled with increased incidences of several zoonotic diseases.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • Global Veterinary healthcare market expanding at 4.9% CAGR over 2020 to 2026 to reach market value of US$ 49.3 Bn by 2026 owing to increased adoption pet animals and rising meat consumption
  • Based on product type feed additives accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Farm animals segment garnered larger revenue share in global 2016 owing to increased animal rearing in several developing and underdeveloped countries
  • Players focusing on mergers and acquisitions strategies to retain market position in global animal healthcare market

Key

Key Features of the Report

Veterinary Healthcare Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Cargill, Inc. (U.S)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Koninklijke DSM N.V. (Netherlands)
  • Merck & Co., Inc. (U.S)
  • Novartis AG (Switzerland)
  • Nutreco N.V. (Netherlands)
  • SeQuent Scientific Ltd. (India)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Description

The global veterinary healthcare market size estimated to be valued US$ 37.4 Bn in 2020 at CAGR of 4.9% and expected to reach US$ 49.3 Bn by 2026 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe. The rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period. Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large-scale production of animals in the form of factory farming expected to boost the animal healthcare market. Animals have long been considered as a source of food for the human being and it’s been shifting towards companionship to the humans. As there is a growing interaction between humans and animals prompting the key stakeholders to give attention to animal healthcare. The rising incidences of zoonotic disease in several developed and developing countries expected to create demand for animal healthcare products like drugs and vaccines over the forecast period. According to U.S. Centre for disease control and Prevention (CDC) every year tens of thousands of people get sick due to disease spread from animals to humans and it is believed that more than six out of every 10 known infectious diseases in people are spread from animals, and three out of every four new or emerging infectious diseases in people are spread from animals, which can be prevented by appropriate health care to animals. In addition, This report includes animal demographics; regulatory scenario, top meat-producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary healthcare market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX